Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2023-05-11 AGM Information
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic ASA: Notice of Annual General Meeting
AGM Information Classification · 99% confidence The document explicitly states 'Navamedic ASA: Notice of Annual General Meeting' and details the date, time, and location for the AGM. Although it mentions the 'Notice of the Annual General Meeting is attached,' the core subject matter is the meeting itself, which aligns best with the AGM Information category. Given the short length (721 chars) and the focus on the meeting notice, it could potentially be RPA, but the specific subject matter (AGM) overrides the general RPA category when AGM-R is available. AGM-R covers 'Presentations and materials shared during the Annual General Meeting (AGM)'. A notice of the meeting falls directly under this scope.
2023-05-11 English
Navamedic ASA Q1 2023: Nok et sterkt kvartal
Investor Presentation Classification · 99% confidence The document text explicitly states "# First quarter 2023 results Navamedic ASA" and contains detailed financial tables for Q1 2023, including revenue, gross margin, EBITDA, balance sheets, and cash flow statements for the period ending March 31, 2023. This structure, focusing on a specific, shorter fiscal period (Q1) with comprehensive financial details, strongly indicates an Interim/Quarterly Report, rather than a full Annual Report (10-K) or just an Earnings Release (ER) which typically contains only highlights. The length (26,794 chars) also suggests a comprehensive report. Therefore, the classification is Interim / Quarterly Report (IR).
2023-05-11 English
Navamedic ASA Q1 2023: Nok et sterkt kvartal
Earnings Release Classification · 98% confidence The document explicitly states it is announcing the results for the first quarter of 2023 ("offentliggjør i dag resultatene for første kvartal 2023"). It provides key financial metrics (revenue, margin, EBITDA, EBIT) for the period. This content aligns perfectly with an Earnings Release (ER). Although it mentions a presentation happening later, the core document provided is the initial release of the period's financial results, not just the announcement of the report's publication (RPA). Since it contains the actual results summary, ER is the most appropriate classification over IR (Interim Report) because ER typically refers to the initial press release summarizing quarterly results, which this text appears to be. Q1 2023
2023-05-11 Norwegian
Navamedic ASA Q1 2023: Another strong quarter
Investor Presentation Classification · 99% confidence The document text explicitly states "# First quarter 2023 results Navamedic ASA" and contains detailed financial tables for Q1 2023, including revenue, gross margin, EBITDA, balance sheets, and cash flow statements for the period ending March 31, 2023. This structure, focusing on a specific, shorter fiscal period (Q1) with comprehensive financial details, strongly indicates an Interim/Quarterly Report, rather than a full Annual Report (10-K) or just an Earnings Release (ER) which typically contains only highlights. The length (26,794 chars) also suggests a comprehensive report. Therefore, the classification is Interim / Quarterly Report (IR).
2023-05-11 English
Navamedic ASA Q1 2023: Another strong quarter
Earnings Release Classification · 100% confidence The document is titled "Navamedic ASA Q1 2023: Another strong quarter" and explicitly states that the company "today announces its results for the first quarter of 2023." It provides key financial highlights (revenues, gross margin, EBITDA) for the first quarter (Q1). This content structure—a brief announcement summarizing key performance indicators for a specific interim period—is characteristic of an Earnings Release (ER). Although it mentions an attached presentation, the primary content provided here is the summary announcement itself, not just the announcement of the publication (which would be RPA/RNS). Since it is a comprehensive summary of quarterly results, ER is the most appropriate classification over IR (Interim Report) which usually implies the full, detailed report. Q1 2023
2023-05-11 English
Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose Aktiebolag
M&A Activity Classification · 98% confidence The document is explicitly titled "Press release" and announces an update to a public offer (takeover bid) for Sensidose Aktiebolag by Navamedic ASA. It details an increase in the cash consideration, an extension of the acceptance period, and a request to convene an extraordinary general meeting (EGM) to change the board. This activity—a public takeover offer, consideration changes, and related EGM/board changes—falls under the scope of M&A Activity (TAR). While it mentions convening an EGM (which relates to AGM/DVA), the primary focus and context is the ongoing takeover bid and the associated price adjustments, making TAR the most appropriate classification. It is not a full 10-K, an ER, or a simple DIV announcement.
2023-05-10 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.